XETRA - Delayed Quote EUR
BioNTech SE (22UA.DE)
102.10
-0.10
(-0.10%)
At close: April 25 at 5:35:49 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
207,700
207,700
5,371,400
13,577,400
889,700
Investing Cash Flow
-2,081,200
-2,081,200
-6,954,500
-35,300
-566,100
Financing Cash Flow
-45,900
-45,900
-778,600
-1,419,300
94,200
End Cash Position
9,761,900
9,761,900
11,663,700
13,875,100
1,692,700
Capital Expenditure
-452,300
-452,300
-705,500
-363,300
-154,000
Issuance of Capital Stock
--
--
--
110,500
160,900
Issuance of Debt
--
--
300
800
--
Repayment of Debt
-45,900
-45,900
-40,400
-59,900
-66,700
Repurchase of Capital Stock
--
--
-738,500
-986,400
--
Free Cash Flow
-244,600
-244,600
4,665,900
13,214,100
735,700
12/31/2021 - 11/6/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0QF.DE Moderna, Inc.
24.44
+3.85%
5CV.DE CureVac N.V.
2.9480
+3.15%
0QF.F Moderna, Inc.
23.67
-0.67%
9VC.DE Atai Life Sciences N.V.
1.3155
-2.01%
VYT.MC Vytrus Biotech, S.A.
3.2000
0.00%
IFRX InflaRx N.V.
1.3000
-1.52%
FYB.DE Formycon AG
23.05
+1.32%
BBZA.DE BB Biotech AG Ord
30.20
-0.33%
BION.SW BB Biotech AG Ord
28.75
+1.77%
GUBRA.CO Gubra A/S
354.00
-2.53%